... 2006, 29:63-65 doi:10.1186/1756-8722-4-9 Cite this article as: Yu et al.: Allogeneichematopoieticstemcelltransplantationfor acute leukemia with Gilbert’s syndrome Journal of Hematology & Oncology ... treatment of GS [8,9] List of abbreviations GS: Gilbert’s syndrome; allo-HSCT: Allogeneichematopoieticstemcell transplantation; AML: acute myeloid leukemia; CR: complete remission; CT: Computed ... http://www.jhoonline.org/content/4/1/9 Page of Figure Bilirubin level during chemotherapy and allogeneichematopoieticstemcelltransplantation Chronological dates of the treatment courses were indicated (A)...
... Background Allogeneichematopoieticstemcelltransplantation (alloHSCT) provides a potentially curing treatment for refractory hematopoietic malignancies and is often the only available treatment for ... RJ, Ho DD, Young JW: Direct evidence for new T -cell generation by patients after either T -cell- depleted or unmodified allogeneichematopoieticstemcell transplantations Blood 2002, 100:2235-42 ... Zhu P: Patterns of T -cell reconstitution by assessment of T -cell receptor excision circle and T -cell receptor clonal repertoire after allogeneichematopoieticstemcelltransplantation in leukemia...
... current status of hematopoieticcelltransplantation Annu Rev Med 2003, 54:491-512 Horowitz MM: Uses and growth of hematopoieticcelltransplantation In Thomas’ hematopoieticcelltransplantation ... preventive practices for long-term survivors after hematopoieticcell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International ... MM, Klein JP, Rizzo JD, Loberiza FR Jr: Trends in survival rates after allogeneichematopoietic stem- celltransplantationfor acute and chronic leukemia by ethnicity in the United States and Canada...
... following hematopoieticstemcelltransplantationHematopoieticstemcelltransplantation (HSCT) is a complex multistep procedure involving mobilisation and harvesting of hematopoieticstem cells ... cytomegalovirus reactivation [49] Mechanisms of action of hematopoieticstemcelltransplantation in autoimmune disease Autologous hematopoieticstemcelltransplantation In autologous HSCT, conditioning ... showing increases in T -cell receptor excision circles and CD31+ T cells and normalisation of new T -cell receptor repertoires [53,54] Allogeneichematopoieticstemcelltransplantation The interaction...
... C: Hematopoieticstemcell transplants from unrelated donors Immunol Rev 1997, 157:141-151 20 21 22 Howe CWS, Radde-Stepaniak T: Hematopoieticcell donor registries In Hematopoieticcelltransplantation ... engraftment after haploidentical stemcelltransplantation Leukemia 2004, 18:1835-1838 Passweg JR, Stern M, Koehl U, et al.: Use of natural killer cells in hematopoetic stemcelltransplantation Bone Marrow ... selection of allogeneic blood stemcell donors J Immunol 2005, 174:6540-6545 Bornhauser M, Schwerdtfeger R, Martin H, et al.: Role of KIR ligand incompatibility in hematopoieticstemcell transplantation...
... reactivation is frequently reported in patients after allogeneicstemcell transplantation, severe disease is rare in patients after autologous stemcelltransplantation Nevertheless, in patients with ... allogeneichematopoieticstemcelltransplantation Leukemia 2002, 16:958-959 Vu T, Carrum G, Hutton G, Heslop HE, Brenner MK, Kamble R: Human herpesvirus-6 encephalitis following allogeneichematopoietic ... herpesvirus-6-associated encephalitis in patients with anterograde amnesia after allogeneichematopoietic stem- celltransplantation AJNR Am J Neuroradiol 2006, 27:887-891 Kim YJ, Kim DW, Lee DG,...
... reactivation is frequently reported in patients after allogeneicstemcell transplantation, severe disease is rare in patients after autologous stemcelltransplantation Nevertheless, in patients with ... allogeneichematopoieticstemcelltransplantation Leukemia 2002, 16:958-959 Vu T, Carrum G, Hutton G, Heslop HE, Brenner MK, Kamble R: Human herpesvirus-6 encephalitis following allogeneichematopoietic ... herpesvirus-6-associated encephalitis in patients with anterograde amnesia after allogeneichematopoietic stem- celltransplantation AJNR Am J Neuroradiol 2006, 27:887-891 Kim YJ, Kim DW, Lee DG,...
... forallogeneichematopoieticstemcelltransplantation In those patients, freedom from infection before engraftment is of the utmost importance ATG administration could be associated with systemic ... undergoing conditioning before hematopoieticstemcelltransplantation represent a distinct population with significantly altered immune response This creates a challenging scenario for clinical diagnosis ... Available online http://ccforum.com/content/13/2/R37 Key messages • Anti-thymocyte globulin (ATG) administered during conditioning before hematopoieticstemcelltransplantation triggered a...
... Ehninger G, Anasetti C: Conditioning with fludarabine and targeted busulfan fortransplantation of allogeneichematopoieticstem cells Blood 2003, 102:820-826 de Lima M, Couriel D, Thall PF, Wang X, ... Kienast J, Hoffken K, Ehninger G, Bornhauser M: Reduced intensity conditioning forallogeneichematopoieticstemcelltransplantation in patients with acute myeloid leukemia: disease status by marrow ... and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen forallogeneicstemcelltransplantation in AML and MDS Blood 2004, 104:857-864 Russell JA, Tran HT, Quinlan...
... blood stemcell transplantation; BMT, bone marrow transplantation; UBMT, unrelated bone marrow transplantation; T-UBMT, T -cell- depleted bone marrow transplantation; UCBT, umbilical cord blood transplantation; ... conventional hematopoieticstemcelltransplantation Blood, 102, 756-762 Parkman, R., & Weinberg, K I (2004) Immune reconstitution following hematopoieticcelltransplantation In K G Blume, S J Forman, ... Ringdén, O (2002) Risk factors for moderate-to-severe chronic graft-versus-host dis ease after allogeneichematopoieticstemcelltransplantation Biology of Blood and Marrow Transplantation, 8, 674-682...
... post -transplantation (AML) cells and donor’s cells Polymorphism DNA repair mechanism Patient cells (pretransplantation) AML cells (posttransplantation) Donor cells XPA A23G NER Homozygous for ... case of a secondary AML developing from donor-derived cells in a breast cancer patient who underwent allogeneicstemcelltransplantation Donor cell leukemia is a rare although well-recognized disease ... informative and showed the coincidence of profile between AML blasts after transplantation and the donor’s cells, supporting full engraftment of the stemcell transplant as well as the donor cell- origin...
... anticoagulation and the risk of hepatic venoocclusive disease in patients undergoing hematopoieticstemcell transplantation: a systematic review and meta-analysis Bone Marrow Transplant 2006, 37:677-686 ... Guinan EC: Multi-institutional use of defibrotide in 88 patients after stemcelltransplantation Page of (page number not for citation purposes) Journal of Medical Case Reports 2009, 3:6164 http://jmedicalcasereports.com/jmedicalcasereports/article/view/6164 ... failure Consent Written informed consent was obtained from the patient for publication of this case report and accompanying images A copy of the written consent is available for review by the Editor-in-Chief...
... Chapter Current Approach to AllogeneicHematopoieticStemCellTransplantation 155 Hugo F Fernandez and Lia Perez Chapter Controversies in Autologous StemCellTransplantationfor the Treatment of Multiple ... antileukemic effect of unmodified allogeneichematopoietic Immunogenetics of HematopoieticStemCellTransplantation http://dx.doi.org/10.5772/54281 stemcelltransplantation in patients with ... Proteasome Inhibition and HematopoieticStemCellTransplantation in Multiple Myeloma 221 Helgi van de Velde and Andrew Cakana Chapter 10 Autologous StemCellTransplantationfor Acute Myeloid Leukemia...
... HLA-identical sibling hematopoietic stem- celltransplantationfor acute myelogenous leukemia predicted Importance of Non-HLA Gene Polymorphisms in HematopoieticStemCellTransplantation 33 by ... of HematopoieticStemCellTransplantation (HSCT) 517 Ami J Shah, Tena Rosser and Fariba Goodarzian Chapter 26 Adenoviral Infection – Common Complication Following HematopoieticStemCellTransplantation ... related to stem cells and Cell Transplantation, we feel it is important to take this opportunity to share these new developments and innovations describing stemcell research in the cell transplantation...
... purified hematopoieticstem cells: in vivo expansion of stemcell phenotype but not function Blood 85, 1006–1016 Li, C L and Johnson, G R (1995) Murine hematopoieticstem and progenitor cells: ... positive cells are collected and reanalyzed for purity and counted For functional transplantation assays, sorted cells are suspended in PBS at the desired cell number or embryo equivalent for injection ... pairs (bp) for LacZ and 245 bp for myogenin The conditions for the YMT-2 male marker-myogenin PCR are: 92oC for min, followed by 30 cycles at 92oC for min, 60oC for min, and 72oC for min, and...
... niche enforces hematopoieticstemcell quiescence and is necessary to preserve self-renewal in vivo CellStemCell Mar 6;2(3):274-83 Fuchs, E.(2008) Skin stem cells: rising to the surface J Cell ... a niche forhematopoieticstem cells Dev Cell Mar;8(3):365-75 Gering, M & Patient R.(2005) Hedgehog signaling is required for adult blood stemcell formation in zebrafish embryos Dev Cell Mar;8(3):389-400 ... distinguish hematopoieticstem and progenitor cells and reveal endothelial niches forstem cells Cell Jul 1;121(7):1109-21 Kiel, M.J.& Morrison, S.J.(2006) Maintaining hematopoieticstem cells in...
... repeats were performed for each biological replicate: this comprises gels for E6 and gels for E7 For each clone we ran three replicates for t0 (control) and three replicates for t48 hours Corresponding ... mES cells, this system allows the efficient and long-term overexpression of the transgene in a dose- and time-dependent manner It is therefore suitable for systematic expression of HSA21 cDNAs Cell ... state (that is, cells grown in the presence of Tc) with those derived from cells grown in a medium deprived of Tc for 48 hours (in other words, cells overexpressing the protein Runx1) For each of...